FDA Inspection 1123741 — Bristol Myers Squibb

Bristol Myers Squibb — FEI 1000527006

The FDA completed an inspection of Bristol Myers Squibb on Apr 22, 2020 in Lawrenceville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 22, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lawrenceville, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.